These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 2969757

  • 1. [Selective anticonvulsive action of N-substituted imidazole-4,5-dicarboxylic acids against quinolinic acid].
    Ryzhov IV, Lapin IP, Piotrovskiĭ LB, Aleksandrova IIa.
    Biull Eksp Biol Med; 1988 Jul; 106(7):64-7. PubMed ID: 2969757
    [Abstract] [Full Text] [Related]

  • 2. [Effects of antagonists of exciting amino acids on the neuro-destructive effect of quinolinic acid in vitro in comparison with their anticonvulsive action in situ].
    Khaspekov LG, Lapin IP, Ryzhov IV, Viktorov IV.
    Biull Eksp Biol Med; 1989 Aug; 108(8):190-3. PubMed ID: 2529920
    [Abstract] [Full Text] [Related]

  • 3. [Synergism of picrotoxin with the endogenous convulsants kynurenine and quinolinic acid and its antagonism with their antagonists].
    Lapin IP, Ryzhov IV.
    Farmakol Toksikol; 1985 Aug; 48(6):13-7. PubMed ID: 3002845
    [Abstract] [Full Text] [Related]

  • 4. [Effect of anticonvulsants on convulsions induced by kynurenine, quinolinic acid, strychnine and corazole].
    Ryzhov IV, Lapin IP.
    Biull Eksp Biol Med; 1981 Dec; 92(12):696-9. PubMed ID: 6459807
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of L-glycine to seizures induced by L-kynurenine, quinolinic acid and strychnine in mice.
    Lapin IP.
    Eur J Pharmacol; 1981 May 22; 71(4):495-8. PubMed ID: 7250201
    [Abstract] [Full Text] [Related]

  • 6. [Effect of gamma-aminobutyric acid and its derivatives on convulsions induced by L-kynurenine and quinolinic acid].
    Ryzhov IV, Lapin IP.
    Farmakol Toksikol; 1981 May 22; 44(2):140-3. PubMed ID: 6456152
    [Abstract] [Full Text] [Related]

  • 7. [Effect of serotoninergic and antiserotoninergic preparations on convulsions induced by the endogenous convulsants kynurenine and quinolinic acid].
    Lapin IP.
    Farmakol Toksikol; 1987 May 22; 50(5):15-8. PubMed ID: 2961608
    [Abstract] [Full Text] [Related]

  • 8. Endogenous antagonists of quinolinic acid and kynurenine as links of the defensive mechanism in epilepsy.
    Lapin IP.
    Acta Neurol (Napoli); 1985 May 22; 7(3-4):203-6. PubMed ID: 2932891
    [No Abstract] [Full Text] [Related]

  • 9. Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles.
    Lapin IP, Prakhie IB, Kiseleva IP.
    J Neural Transm; 1986 May 22; 65(3-4):177-85. PubMed ID: 2940335
    [Abstract] [Full Text] [Related]

  • 10. [The action of 3-indolepyruvate in quinolinate-induced convulsions in mice].
    Mirzaev S, Ryzhov IV.
    Farmakol Toksikol; 1991 May 22; 54(5):10-1. PubMed ID: 1839285
    [Abstract] [Full Text] [Related]

  • 11. [Convulsions induced by kynurenine and quinolinic acid as a sensitive test for assessing the anticonvulsant activity of GABA-ergic preparations].
    Lapin IP, Ryzhov IV.
    Biull Eksp Biol Med; 1983 Apr 22; 95(4):53-5. PubMed ID: 6299432
    [Abstract] [Full Text] [Related]

  • 12. [Stimulatory effects of intraventricular administration of kynurenines, amino acids, and convulsants: differences between rats and mice].
    Prakh'e IB, Kiseleva IP, Lapin IP.
    Fiziol Zh SSSR Im I M Sechenova; 1982 Nov 22; 68(11):1516-21. PubMed ID: 7152052
    [Abstract] [Full Text] [Related]

  • 13. Convulsant action of intracerebroventricularly administered l-kynurenine sulphate, quinolinic acid and other derivatives of succinic acid, and effects of amino acids: structure-activity relationships.
    Lapin IP.
    Neuropharmacology; 1982 Dec 22; 21(12):1227-33. PubMed ID: 6218422
    [Abstract] [Full Text] [Related]

  • 14. Anticonvulsant action of beta-kainic acid in mice. Is beta-kainic acid an N-methyl-D-aspartate antagonist?
    Turski L, Meldrum BS, Collins JF.
    Brain Res; 1985 Jun 10; 336(1):162-6. PubMed ID: 2860949
    [Abstract] [Full Text] [Related]

  • 15. [The neurodegenerative and convulsant action of quinolinic acid].
    Kozlovskiĭ VL, Prakh'e IV, Geĭnisman NV.
    Neirofiziologiia; 1990 Jun 10; 22(3):354-9. PubMed ID: 2144614
    [Abstract] [Full Text] [Related]

  • 16. (R,S)-4-phosphonophenylglycine, a potent and selective group III metabotropic glutamate receptor agonist, is anticonvulsive and neuroprotective in vivo.
    Gasparini F, Bruno V, Battaglia G, Lukic S, Leonhardt T, Inderbitzin W, Laurie D, Sommer B, Varney MA, Hess SD, Johnson EC, Kuhn R, Urwyler S, Sauer D, Portet C, Schmutz M, Nicoletti F, Flor PJ.
    J Pharmacol Exp Ther; 1999 Jun 10; 289(3):1678-87. PubMed ID: 10336568
    [Abstract] [Full Text] [Related]

  • 17. [Effect of some imidazole-4,5-dicarboxylic acid derivatives on the activity of N-methyl-D-aspartate (NMDA) receptors].
    Efremov OM, Aleksandrova IIa, Kulikov SV, Losev NA, Piotrovskiĭ LB.
    Eksp Klin Farmakol; 2005 Jun 10; 68(1):7-9. PubMed ID: 15786955
    [Abstract] [Full Text] [Related]

  • 18. [Behavioral and EEG signs of the convulsive action of kynurenine and quinolinic acid in cats].
    Dutov AA, Tolpyshev BA.
    Farmakol Toksikol; 1987 Jun 10; 50(3):33-6. PubMed ID: 2956122
    [Abstract] [Full Text] [Related]

  • 19. On the interaction of 2-amino-7-phosphono-heptanoic acid and quinolinic acid in mice.
    Perkins MN, Stone TW.
    Eur J Pharmacol; 1983 May 06; 89(3-4):297-300. PubMed ID: 6347698
    [Abstract] [Full Text] [Related]

  • 20. [Pharmacologic modulation of central noradrenergic mechanisms and the effect of selected substances on chemically-induced seizures: the maximal quinolinic acid seizure test (mouse)].
    Fischer W, Ryzov IV, Lapin IP.
    Pharmazie; 1991 Apr 06; 46(4):301-3. PubMed ID: 1832228
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.